key: cord-0828229-jwtled3y
authors: Sidlow, Jonathan S.; Reichel, Theodora R.; Reichel, Martin; Lowenstein, Eve J.
title: Localized and Generalized Urticarial Allergic Dermatitis Secondary to SARS-CoV-2 Vaccination in a Series of Six Patients
date: 2021-06-05
journal: JAAD Case Rep
DOI: 10.1016/j.jdcr.2021.05.018
sha: eaafba719d8590d63acf6ecc10a6f39e7de89d34
doc_id: 828229
cord_uid: jwtled3y

nan

In response to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, 43 two mRNA lipid-stabilized vaccines involving new technologies have been launched with unprecedented 44 urgency. Early post-release data has shown these vaccines to be highly effective and safe. Some 

The conclusions that may be drawn based upon this small number of cases is limited. 

recommendation for allocating initial supplies of COVID-19 vaccine-United States

Immediate Hypersensitivity to Polyethylene Glycols and